LMR Partners’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-151,698
Closed -$7.05M – 1098
2023
Q2
$7.05M Buy
+151,698
New +$5.24M 0.08% 220
2022
Q1
– Sell
-15,387
Closed -$389K – 1394
2021
Q4
$389K Sell
15,387
-44,613
-74% -$1.31M ﹤0.01% 970
2021
Q3
$1.96M Buy
+60,000
New +$2.04M 0.02% 460

LMR Partners's DICE Position: Q3 2023 in Review

LMR Partners sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 151,698 shares — an estimated $7.05M sold.

LMR Partners first reported a position in DICE in Q3 2021 and held it in 3 quarters. The position peaked at $7.05M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • LMR Partners reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • LMR Partners sold 151,698 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $7.05M.
  • LMR Partners first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • LMR Partners's DICE Therapeutics, Inc. Common Stock position peaked at $7.05M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on LMR Partners's 13F filing for Q3 2023, filed 14 Nov 2023.